an innovative clinical stage biotechnology company that is developing novel pain relief treatments for osteoarthritis

Moshe Weinstein

CEO

Dr. Yaniv Dolev

Founder & VP R&D

Prof. Chezy Barenholz

Co-inventor & Board Member

Clinical-stage biotech company developing novel pain relief treatments for osteoarthritis

Moebius Medical is a clinical stage biotechnology company that has used patented technology licensed from the Hebrew University, Technion and Hadassah Medical Center to develop novel pain relief treatments for osteoarthritis patients.

Moebius’s lead product, MM-II, is a patent-protected intra-articular biolubricant injection that is proving effective in the treatment of mild-to-moderate symptomatic knee osteoarthritis (OA). 
 
In 2016, Moebius Medical entered into an exclusive worldwide licensing deal for MM-II with India's Sun Pharmaceutical Industries Ltd. to develop MM-II.